Nemtabrutinib With CAR T Therapy in Relapsed/Refractory Mantle Cell Lymphoma
Clinical trial NCT07673367 · RECRUITING
Trial details
- NCT number
- NCT07673367
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-31
- Primary completion
- 2031-07-31
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.